ACRS

Aclaris Therapeutics (ACRS)

About Aclaris Therapeutics (ACRS)

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Details

Daily high

$5.12

Daily low

$4.77

Price at open

$4.77

52 Week High

$5.15

52 Week Low

$1.38

Market cap

676.0M

Dividend yield

0.00%

Volume

1.1M

Avg. volume

1.4M

P/E ratio

-8.64

Aclaris Therapeutics News

Details

Daily high

$5.12

Daily low

$4.77

Price at open

$4.77

52 Week High

$5.15

52 Week Low

$1.38

Market cap

676.0M

Dividend yield

0.00%

Volume

1.1M

Avg. volume

1.4M

P/E ratio

-8.64